Cargando…
Serological Evaluation of Soluble CD44 in Renal Cancer
In this study, we examined the feasibility of using elevated serum CD44 concentration as an indicator in renal cancer. We performed enzyme‐linked immunosorbent assays using 63 sera obtained from 47 patients with renal cancer and 16 healthy controls and evaluated the clinico‐pathological parameters....
Autores principales: | Kan, Masaharu, Kanayama, Hiro‐omi, Naruo, Seiichi, Tsuji, Masahito, Kojima, Keiji, Kurokawa, Yasushi, Kagawa, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921015/ https://www.ncbi.nlm.nih.gov/pubmed/9045950 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03131.x |
Ejemplares similares
-
High‐level Expression of the CD44 Variant Sharing Exon v10 in Renal Cancer
por: Kan, Masaharu, et al.
Publicado: (1995) -
Unusual trivial trauma may end with extrusion of a well-functioning penile prosthesis: a case report
por: Salama, Nader, et al.
Publicado: (2007) -
Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Čēma, Ingrīda, et al.
Publicado: (2021) -
Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995) -
Glioblastoma-secreted soluble CD44 activates tau pathology in the brain
por: Lim, Sungsu, et al.
Publicado: (2018)